Header Logo

Connection

MICHAEL JAMES OVERMAN to Splenic Infarction

Back to Details
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Splenic Infarction.
MICHAEL JAMES OVERMAN
Connection Strength
0.182
Splenic Infarction
  1. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism. Clin Colorectal Cancer. 2020 12; 19(4):e189-e199.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.